Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › riociguat

riociguat

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of riociguat

3 trials tracked of riociguat: 1 in phase 3 or 4.

3Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 2 2
  1. Phase 4 Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude Completed
  2. Phase 2 A Multi-Center Study of Riociguat in Patients With Sickle Cell Diseases Completed
  3. Phase 2 Riociguat in Scleroderma Associated Digital Ulcers Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Narrative review finds insufficient evidence for CFTR modulator monotherapy in cystic fibrosis with F508del homozygosity
Pediatrics Sys. Review
Narrative review finds insufficient evidence for CFTR modulator monotherapy in cystic fibrosis with F508del homozygosity New review shows single drug therapy does not help people with cystic fibrosis who have two F508del gene variants
This narrative review synthesized evidence from 10 early-phase trials on CFTR modulator monotherapy for cystic fibrosis with F508del homozyg…
A review of early studies found that taking one CFTR modulator drug alone does not improve survival, lung function, or quality of life for p…
Cochrane May 13, 2026